KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $21.39 $29.07 Friday, 26th Apr 2024 ARWR stock ended at $22.12. This is 1.14% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.95% from a day low at $21.72 to a day high of $22.36.
90 days $21.39 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Mar 26, 2021 $65.46 $65.71 $61.32 $62.95 882 791
Mar 25, 2021 $61.54 $65.61 $61.03 $65.21 1 204 118
Mar 24, 2021 $66.23 $67.25 $62.43 $62.82 810 156
Mar 23, 2021 $69.13 $69.73 $65.78 $66.07 729 672
Mar 22, 2021 $68.77 $71.10 $68.26 $70.50 756 289
Mar 19, 2021 $67.86 $68.85 $65.59 $67.40 1 992 683
Mar 18, 2021 $71.01 $71.75 $67.69 $67.84 681 231
Mar 17, 2021 $70.47 $73.38 $69.50 $72.57 460 241
Mar 16, 2021 $73.40 $74.46 $70.44 $71.97 510 295
Mar 15, 2021 $72.90 $73.21 $70.48 $71.85 795 955
Mar 12, 2021 $72.11 $72.84 $70.32 $72.74 513 180
Mar 11, 2021 $71.61 $73.64 $70.87 $73.18 655 460
Mar 10, 2021 $71.44 $73.48 $69.20 $69.63 723 600
Mar 09, 2021 $65.82 $71.50 $65.81 $69.87 912 198
Mar 08, 2021 $69.10 $71.08 $64.30 $64.58 1 187 414
Mar 05, 2021 $70.00 $70.50 $62.99 $69.00 1 610 045
Mar 04, 2021 $77.08 $77.08 $68.07 $69.56 1 763 646
Mar 03, 2021 $80.61 $80.97 $75.17 $75.48 889 753
Mar 02, 2021 $83.25 $83.89 $80.32 $80.63 721 133
Mar 01, 2021 $81.14 $84.45 $81.06 $83.78 566 453
Feb 26, 2021 $83.01 $84.49 $78.91 $79.66 1 053 117
Feb 25, 2021 $84.16 $86.44 $81.10 $82.20 614 724
Feb 24, 2021 $82.48 $85.48 $80.42 $85.03 687 269
Feb 23, 2021 $82.82 $83.00 $78.01 $81.75 1 311 872
Feb 22, 2021 $88.29 $89.37 $84.71 $85.00 765 678
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT